Raising needs for better techniques in Mycoplasma Diagnostics market industry to be major
market driver.
According to WHO 2016, the advance techniques such as Polymerase Chain Reaction (PCR),
DNA staining and Immunoassay have dominated the market. However, remarkable growth is
observed in use of techniques, such as ELISA and RIA. These techniques are cost effective and
they are used in pharmaceutical and diagnostic industries, due to their ease of use and
availability.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/mycoplasma-diagnostics-market-763
The major key players in the global mycoplasma diagnostics market industry are: Agilent
Technologies, American Type Culture Collection (ATCC), Thermo Fisher Scientific, Takara
Holding, PromoCell GmbH, Merck KGaA, Lonza Group, Savyon Diagnostics, Tecan Group,
Charles River Laboratories International, F Hoffmann-La Roche and Sartorius Stedim
BioOutsource. Major role players in the global mycoplasma diagnostic industries, such as
Thermo Fishers Scientifics and Merck KGaA holds around 23% share in the global market,
which increases the opportunities towards the profitable and global market insights in
Mycoplasma Diagnostics.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com